Join Australian delegation to The MedTech Conference
MTPConnect is inviting medical technology innovators to join the Australian delegation to The MedTech Conference, to be held from 23–26 September in Philadelphia, Pennsylvania. The delegation will showcase outstanding innovative medical technologies, Australia's unique capabilities and build inroads into international markets.
The MedTech Conference brings together thousands of medical technology professionals from the US and across the globe and provides intensive networking opportunities to connect with international specialists in policy, innovation, business development and investment.
The MTPConnect Australian Pavilion will provide opportunity in a high-traffic area for participants to leverage Australian branding to attract R&D investment, engage in collaborative partnerships and establish their company as a global leader in the medical technologies industry.
Participants in the Australian delegation can take advantage of tailored packages (TBC) set to include benefits such as: discounted registration rates; access to programs and seminars exclusive to the Australian delegation, and invitation-only events; tailored site visits with the Australian delegation; branding opportunities and exposure via MTPConnect Australian stand; promotion via Australian mission booklet; access to brochure stands; access to informal, open plan meeting areas on the stand; listing of company details on the MedTech Conference Directory.
MTPConnect is also working closely with conference organisers to pitch Australian delegates for speaking opportunities. Expressions of interest are now open to join the delegation and discuss requirements — interested parties are encouraged to submit their EOI as soon as possible be involved in program planning.
Professor Tony Haymet appointed Australia's Chief Scientist
Emeritus Professor Tony Haymet — a world-leading oceanographer, chemist and entrepreneur...
NZ announces significant reforms to science sector
The reforms are intended to maximise the value of the $1.2 billion in government funding that...
Vaxxas to advance its microarray patches for COVID vaccination
Vaxxas will receive AU$3.2m from BARDA to accelerate work advancing its high-density microarray...